SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000950144-05-010320
Filing Date
2005-10-13
Accepted
2005-10-13 17:11:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 NOVAVAX, INC./KING PHARMACEUTICALS, INC. g97588sc13dza.htm SC 13D/A 35743
  Complete submission text file 0000950144-05-010320.txt   37629
Mailing Address 508 LAPP ROAD MALVERN PA 19355
Business Address 508 LAPP ROAD MALVERN PA 19355 4849131200
NOVAVAX INC (Subject) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-48948 | Film No.: 051137280
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 501 FIFTH ST BRISTOL TN 37620
Business Address 501 FIFTH ST BRISTOL TN 37620 4239898000
KING PHARMACEUTICALS INC (Filed by) CIK: 0001047699 (see all company filings)

IRS No.: 541684963 | State of Incorp.: TN | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations